Literature DB >> 25855668

Pulmonary artery enlargement is associated with right ventricular dysfunction and loss of blood volume in small pulmonary vessels in chronic obstructive pulmonary disease.

J Michael Wells1, Anand S Iyer2, Farbod N Rahaghi2, Surya P Bhatt2, Himanshu Gupta2, Thomas S Denney2, Steven G Lloyd2, Louis J Dell'Italia2, Hrudaya Nath2, Raul San Jose Estepar2, George R Washko2, Mark T Dransfield2.   

Abstract

BACKGROUND: Chronic obstructive pulmonary disease causes significant morbidity and concomitant pulmonary vascular disease and cardiac dysfunction are associated with poor prognosis. Computed tomography-detected relative pulmonary artery (PA) enlargement defined as a PA to ascending aorta diameter ratio >1 (PA:A>1) is a marker for pulmonary hypertension and predicts chronic obstructive pulmonary disease exacerbations. However, little is known about the relationship between the PA:A ratio, pulmonary blood volume, and cardiac function. METHODS AND
RESULTS: A single-center prospective cohort study of patients with chronic obstructive pulmonary disease was conducted. Clinical characteristics and computed tomography metrics, including the PA:A and pulmonary blood vessel volume, were measured. Ventricular functions, volumes, and dimensions were measured by cine cardiac MRI with 3-dimensional analysis. Linear regression examined the relationships between clinical characteristics, computed tomography and cardiac MRI metrics, and 6-minute walk distance. Twenty-four patients were evaluated and those with PA:A>1 had higher right ventricular (RV) end-diastolic and end-systolic volume indices accompanied by lower RV ejection fraction (52±7% versus 60±9%; P=0.04). The PA:A correlated inversely with total intraparenchymal pulmonary blood vessel volume and the volume of distal vessels with a cross-sectional area of <5 mm(2). Lower forced expiratory volume, PA:A>1, and hyperinflation correlated with reduced RV ejection fraction. Both PA diameter and reduced RV ejection fraction were independently associated with reduced 6-minute walk distance.
CONCLUSIONS: The loss of blood volume in distal pulmonary vessels is associated with PA enlargement on computed tomography. Cardiac MRI detects early RV dysfunction and remodeling in nonsevere chronic obstructive pulmonary disease patients with a PA:A>1. Both RV dysfunction and PA enlargement are independently associated with reduced walk distance. CLINICAL TRIAL REGISTRATION: URL: http://www.clinicaltrials.gov. Unique identifier: NCT00608764.
© 2015 American Heart Association, Inc.

Entities:  

Keywords:  cardiac magnetic resonance imaging; hypertension, pulmonary; pulmonary disease; pulmonary heart disease; smoking

Mesh:

Year:  2015        PMID: 25855668      PMCID: PMC4392846          DOI: 10.1161/CIRCIMAGING.114.002546

Source DB:  PubMed          Journal:  Circ Cardiovasc Imaging        ISSN: 1941-9651            Impact factor:   7.792


  41 in total

1.  Evaluation of right ventricular remodeling using cardiac magnetic resonance imaging in co-existent chronic obstructive pulmonary disease and obstructive sleep apnea.

Authors:  Bhavneesh Sharma; Tomas G Neilan; Raymond Y Kwong; Damien Mandry; Robert L Owens; David McSharry; Jessie P Bakker; Atul Malhotra
Journal:  COPD       Date:  2012-12-28       Impact factor: 2.409

2.  Assessment of the right ventricular function in patients with chronic obstructive pulmonary disease using MRI.

Authors:  Yan Gao; Xiangying Du; Wen Qin; Kuncheng Li
Journal:  Acta Radiol       Date:  2011-09-01       Impact factor: 1.990

3.  Echocardiographic abnormalities in patients with COPD at their first hospital admission.

Authors:  Xavier Freixa; Karina Portillo; Carles Paré; Judith Garcia-Aymerich; Federico P Gomez; Marta Benet; Josep Roca; Eva Farrero; Jaume Ferrer; Carlos Fernandez-Palomeque; Josep M Antó; Joan Albert Barberà
Journal:  Eur Respir J       Date:  2012-09-27       Impact factor: 16.671

4.  Treatment of acute chronic obstructive pulmonary disease exacerbation improves right ventricle function.

Authors:  Murat Akcay; Ekrem Yeter; Tahir Durmaz; Telat Keles; Nihal Akar Bayram; Meral Uyar; Vedat Davutoglu; Isa Yüksel; Mustafa Kurt; Engin Bozkurt
Journal:  Eur J Echocardiogr       Date:  2010-03-10

5.  Improvements in symptom-limited exercise performance over 8 h with once-daily tiotropium in patients with COPD.

Authors:  François Maltais; Alan Hamilton; Darcy Marciniuk; Paul Hernandez; Frank C Sciurba; Kai Richter; Steven Kesten; Denis O'Donnell
Journal:  Chest       Date:  2005-09       Impact factor: 9.410

6.  [Evaluation of left ventricular function in patients with chronic obstructive pulmonary disease].

Authors:  Elzbieta Suchoń; Wiesława Tracz; Piotr Podolec; Monika Pieculewicz; Wojciech Płazak; Anna Prokop; Piotr Nalepa
Journal:  Pol Arch Med Wewn       Date:  2007-03

7.  Percent emphysema, airflow obstruction, and impaired left ventricular filling.

Authors:  R Graham Barr; David A Bluemke; Firas S Ahmed; J Jeffery Carr; Paul L Enright; Eric A Hoffman; Rui Jiang; Steven M Kawut; Richard A Kronmal; João A C Lima; Eyal Shahar; Lewis J Smith; Karol E Watson
Journal:  N Engl J Med       Date:  2010-01-21       Impact factor: 91.245

8.  Right ventricular remodelling in pulmonary arterial hypertension with three-dimensional echocardiography: comparison with cardiac magnetic resonance imaging.

Authors:  Julia Grapsa; Declan P O'Regan; Harry Pavlopoulos; Giuliana Durighel; David Dawson; Petros Nihoyannopoulos
Journal:  Eur J Echocardiogr       Date:  2009-11-24

9.  Early diagnosis of right ventricular systolic dysfunction by tissue Doppler-derived isovolumic myocardial acceleration in patients with chronic obstructive pulmonary disease.

Authors:  Yelda Tayyareci; Gulsah Tayyareci; Cagla Pinar Tastan; Pelin Bayazit; Yilmaz Nisanci
Journal:  Echocardiography       Date:  2009-10       Impact factor: 1.724

Review 10.  Cardiac magnetic resonance imaging: what can it add to our knowledge of the right ventricle in pulmonary arterial hypertension?

Authors:  Anton Vonk-Noordegraaf; Rogério Souza
Journal:  Am J Cardiol       Date:  2012-09-15       Impact factor: 2.778

View more
  36 in total

1.  Pulmonary Arterial Stiffness: Toward a New Paradigm in Pulmonary Arterial Hypertension Pathophysiology and Assessment.

Authors:  Michal Schäfer; Cynthia Myers; R Dale Brown; Maria G Frid; Wei Tan; Kendall Hunter; Kurt R Stenmark
Journal:  Curr Hypertens Rep       Date:  2016-01       Impact factor: 5.369

2.  Arterial and Venous Pulmonary Vascular Morphology and Their Relationship to Findings in Cardiac Magnetic Resonance Imaging in Smokers.

Authors:  Farbod N Rahaghi; J Michael Wells; Carolyn E Come; Isaac A De La Bruere; Surya P Bhatt; James C Ross; Gonzalo Vegas-Sánchez-Ferrero; Alejandro A Diaz; Jasleen Minhas; Mark T Dransfield; Raúl San José Estépar; George R Washko
Journal:  J Comput Assist Tomogr       Date:  2016 Nov/Dec       Impact factor: 1.826

3.  Pulmonary vascular morphology as an imaging biomarker in chronic thromboembolic pulmonary hypertension.

Authors:  F N Rahaghi; J C Ross; M Agarwal; G González; C E Come; A A Diaz; G Vegas-Sánchez-Ferrero; A Hunsaker; R San José Estépar; A B Waxman; G R Washko
Journal:  Pulm Circ       Date:  2016-03       Impact factor: 3.017

Review 4.  Imaging approaches to understand disease complexity: chronic obstructive pulmonary disease as a clinical model.

Authors:  Karin J C Sanders; Samuel Y Ash; George R Washko; Felix M Mottaghy; Annemie M W J Schols
Journal:  J Appl Physiol (1985)       Date:  2017-07-27

5.  Cardiac Morphometry on Computed Tomography and Exacerbation Reduction with β-Blocker Therapy in Chronic Obstructive Pulmonary Disease.

Authors:  Surya P Bhatt; Gonzalo Vegas-Sánchez-Ferrero; Farbod N Rahaghi; Erick S MacLean; German Gonzalez-Serrano; Carolyn E Come; Gregory L Kinney; John E Hokanson; Matthew J Budoff; Michael J Cuttica; J Michael Wells; Raúl San José Estépar; George R Washko
Journal:  Am J Respir Crit Care Med       Date:  2017-12-01       Impact factor: 21.405

6.  Smaller Left Ventricle Size at Noncontrast CT Is Associated with Lower Mortality in COPDGene Participants.

Authors:  George R Washko; Pietro Nardelli; Samuel Y Ash; Farbod N Rahaghi; Gonzalo Vegas Sanchez-Ferrero; Carolyn E Come; Mark T Dransfield; Ravi Kalhan; MeiLan K Han; Surya P Bhatt; J Michael Wells; Carrie L Pistenmaa; Alejandro A Diaz; James C Ross; Stephen Rennard; Gabriela Querejeta Roca; Amil M Shah; Kendra Young; Gregory L Kinney; John E Hokanson; Alvar Agustí; Raúl San José Estépar
Journal:  Radiology       Date:  2020-05-05       Impact factor: 11.105

7.  Pulmonary artery enlargement and mortality risk in moderate to severe COPD: results from COPDGene.

Authors:  David C LaFon; Surya P Bhatt; Wassim W Labaki; Farbod N Rahaghi; Matthew Moll; Russ P Bowler; Elizabeth A Regan; Barry J Make; James D Crapo; Raul San Jose Estepar; Alejandro A Diaz; Edwin K Silverman; MeiLan K Han; Brian Hobbs; Michael H Cho; George R Washko; Mark T Dransfield; J Michael Wells
Journal:  Eur Respir J       Date:  2020-02-12       Impact factor: 16.671

8.  Ventricular Geometry From Non-contrast Non-ECG-gated CT Scans: An Imaging Marker of Cardiopulmonary Disease in Smokers.

Authors:  Farbod N Rahaghi; Gonzalo Vegas-Sanchez-Ferrero; Jasleen K Minhas; Carolyn E Come; Isaac De La Bruere; James M Wells; Germán González; Surya P Bhatt; Brett E Fenster; Alejandro A Diaz; Puja Kohli; James C Ross; David A Lynch; Mark T Dransfield; Russel P Bowler; Maria J Ledesma-Carbayo; Raúl San José Estépar; George R Washko
Journal:  Acad Radiol       Date:  2017-02-15       Impact factor: 3.173

9.  Diffusing Capacity of Carbon Monoxide in Assessment of COPD.

Authors:  Aparna Balasubramanian; Neil R MacIntyre; Robert J Henderson; Robert L Jensen; Gregory Kinney; William W Stringer; Craig P Hersh; Russell P Bowler; Richard Casaburi; MeiLan K Han; Janos Porszasz; R Graham Barr; Barry J Make; Robert A Wise; Meredith C McCormack
Journal:  Chest       Date:  2019-07-25       Impact factor: 9.410

10.  Arterial Vascular Pruning, Right Ventricular Size, and Clinical Outcomes in Chronic Obstructive Pulmonary Disease. A Longitudinal Observational Study.

Authors:  George R Washko; Pietro Nardelli; Samuel Y Ash; Gonzalo Vegas Sanchez-Ferrero; Farbod N Rahaghi; Carolyn E Come; Mark T Dransfield; Ravi Kalhan; MeiLan K Han; Surya P Bhatt; J Michael Wells; Carrie Pistenmaa Aaron; Alejandro A Diaz; James C Ross; Michael J Cuttica; Wassim W Labaki; Gabriela Querejeta Roca; Amil M Shah; Kendra Young; Gregory L Kinney; John E Hokanson; Alvar Agustí; Raúl San José Estépar
Journal:  Am J Respir Crit Care Med       Date:  2019-08-15       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.